1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. NORDIC PORTABLE GLUCOSE MARKET BY PRODUCT
5.1. Introduction
5.2. Invasive
5.2.1. Self-Monitoring Blood Glucose (SMBG Devices)
5.2.2. Continuous Glucose Monitoring (CGM) Systems
5.3. Non-Invasive
5.3.1. Optical-Based
5.3.2. Electromagnetic-Based
5.3.3. Others
6. NORDIC PORTABLE GLUCOSE MARKET BY TYPE
6.1. Introduction
6.2. Wearable
6.3. Non-Wearable
7. NORDIC PORTABLE GLUCOSE MARKET BY DEMOGRAPHICS
7.1. Introduction
7.2. Pediatric Population
7.3. Adult Population
7.4. Geriatric Population
8. NORDIC PORTABLE GLUCOSE MARKET BY END-USER
8.1. Introduction
8.2. Hospitals and Diagnostic Centers
8.3. Home Care
8.4. Specialty Clinics
9. NORDIC PORTABLE GLUCOSE MARKET BY GEOGRAPHY
9.1. Introduction
9.2. Norway
9.3. Sweden
9.4. Denmark
9.5. Finland
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. RSP Systems A/S
11.2. Ascensia Diabetes Care Holdings AG
11.3. Abbott Laboratories
11.4. Dexcom, Inc.
11.5. Roche Diabetes Care, Inc.
11.6. Medtronic plc
11.7. Insulet Corporation
11.8. Lifescan Inc.
11.9. Senseonics Holdings Inc.
11.10. Tandem Diabetes Care Inc.
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key Benefits for the Stakeholders
12.5. Research Methodology
12.6. AbbreviationsLIST OF FIGURESLIST OF TABLES